Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.93 AUD | +0.61% | -1.00% | -19.84% |
06-03 | Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland | MT |
05-24 | Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.84% | 264M | |
+18.09% | 41.07B | |
+24.16% | 22.65B | |
+15.71% | 15.02B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-10.97% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.59B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma Group Completes Exclusive Product Licensing Deal